These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10227513)

  • 1. Platelet glycoprotein IIb/IIIa receptor antagonist used in conjunction with thrombolysis for peripheral arterial thrombosis.
    Tepe G; Schott U; Erley CM; Albes J; Claussen CD; Duda SH
    AJR Am J Roentgenol; 1999 May; 172(5):1343-6. PubMed ID: 10227513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study.
    Lee DH; Jo KD; Kim HG; Choi SJ; Jung SM; Ryu DS; Park MS
    J Vasc Interv Radiol; 2002 Aug; 13(8):769-74. PubMed ID: 12171979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined glycoprotein IIb/IIIa receptor inhibition and low-dose fibrinolysis for peripheral arterial thrombosis.
    Rocha-Singh KJ; Trokey J
    Catheter Cardiovasc Interv; 2002 Apr; 55(4):457-60. PubMed ID: 11948891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral artery occlusion: treatment with abciximab plus urokinase versus with urokinase alone--a randomized pilot trial (the PROMPT Study). Platelet Receptor Antibodies in Order to Manage Peripheral Artery Thrombosis.
    Duda SH; Tepe G; Luz O; Ouriel K; Dietz K; Hahn U; Pereira P; Marsalek P; Ziemer G; Erley CM; Claussen CD
    Radiology; 2001 Dec; 221(3):689-96. PubMed ID: 11719664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The adjuvant use of the monoclonal antibody c7E3 Fab in peripheral arterial thrombolysis].
    Tepe G; Duda SH; Erley CM; Schott U; Huppert PE; Claussen CD
    Rofo; 1997 Mar; 166(3):254-7. PubMed ID: 9156599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by combination with a humanized anti-glycoprotein IIb/IIIa monoclonal antibody, YM337, in a rhesus monkey model of coronary thrombosis.
    Kawasaki T; Sato K; Suzuki K; Sakai Y; Taniuchi Y; Kaku S; Yano S; Inagaki O; Tomioka K; Masuho Y; Yanagisawa I; Takenaka T
    Thromb Haemost; 1998 Mar; 79(3):663-7. PubMed ID: 9531059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using a peptide inhibitor of the glycoprotein IIb/IIIa platelet receptor: initial experience in patients with acute peripheral arterial occlusions.
    Yoon HC; Miller FJ
    AJR Am J Roentgenol; 2002 Mar; 178(3):617-22. PubMed ID: 11856686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience with the combination of reteplase and abciximab for thrombolytic therapy in peripheral arterial occlusive disease: a pilot study.
    Drescher P; Crain MR; Rilling WS
    J Vasc Interv Radiol; 2002 Jan; 13(1):37-43. PubMed ID: 11788692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clot lysis in a primate model of peripheral arterial occlusive disease with use of systemic or intraarterial reteplase: addition of abciximab results in improved vessel reperfusion.
    Nakada MT; Montgomery MO; Nedelman MA; Guerrero JL; Cohen SA; Barnathan ES; Jordan RE
    J Vasc Interv Radiol; 2004 Feb; 15(2 Pt 1):169-76. PubMed ID: 14963184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study.
    Heo JH; Lee KY; Kim SH; Kim DI
    Neurology; 2003 May; 60(10):1684-7. PubMed ID: 12771267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral occlusive arterial disease and arterial thrombosis.
    Schweizer J; Kirch W; Koch R; Müller A; Hellner G; Forkmann L
    Angiology; 2000 Nov; 51(11):913-23. PubMed ID: 11103860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral arteries: treatment with antibodies of platelet receptors and reteplase for thrombolysis--APART trial.
    Tepe G; Hopfenzitz C; Dietz K; Wiskirchen J; Heller S; Ouriel K; Ziemer G; Claussen CD; Duda SH
    Radiology; 2006 Jun; 239(3):892-900. PubMed ID: 16641342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial.
    Greenbaum AB; Grines CL; Bittl JA; Becker RC; Kereiakes DJ; Gilchrist IC; Clegg J; Stankowski JE; Grogan DR; Harrington RA; Emanuelsson H; Weaver WD
    Am Heart J; 2006 Mar; 151(3):689.e1-689.e10. PubMed ID: 16504633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraarterially administered abciximab as an adjuvant thrombolytic therapy: report of three cases.
    Kwon OK; Lee KJ; Han MH; Oh CW; Han DH; Koh YC
    AJNR Am J Neuroradiol; 2002 Mar; 23(3):447-51. PubMed ID: 11901016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728.
    Mousa SA; Forsythe MS; Diemer M; Bozarth JM; Reilly TM
    Coron Artery Dis; 1994 Nov; 5(11):919-27. PubMed ID: 7719524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic dissolution of an intracoronary thrombus by prolonged intravenous platelet glycoprotein IIb/IIIa antagonism.
    Radke PW; Janssens U; Schwarz ER; vom Dahl J
    J Invasive Cardiol; 1999 Nov; 11(11):679-81. PubMed ID: 10745462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Rescue platelet glycoprotein IIb/IIIa inhibitor therapy in thrombosis complicating superficial femoral artery angioplasty.
    Grollman JH; Coil A
    Cardiovasc Intervent Radiol; 2002; 25(1):77-80. PubMed ID: 11907783
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of a large intracoronary thrombus with urokinase and a chimeric monoclonal platelet aggregation inhibitor].
    Eick B; Haude M; Altmann C; Liu F; Caspari G; Leischik R; Erbel R
    Dtsch Med Wochenschr; 1997 May; 122(22):709-15. PubMed ID: 9213535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic value of thrombolysis with adjunctive abciximab in patients with subacute peripheral arterial occlusion.
    Duda SH; Tepe G; Bala M; Luz O; Ziemer G; Ouriel K; Pusich B; Wiskirchen J; Claussen CD; Banz K
    Pharmacoeconomics; 2002; 20(3):203-13. PubMed ID: 11929350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter-directed thrombolytic therapy in peripheral artery occlusions: combining reteplase and abciximab.
    Drescher P; McGuckin J; Rilling WS; Crain MR
    AJR Am J Roentgenol; 2003 May; 180(5):1385-91. PubMed ID: 12704056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.